发明名称 NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
摘要 A method for treating Chronic Fatigue Syndrome or alleviating symptoms thereof wherein the reduced form of nicotinamide adenine dinucleotide (NADH) or the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) or physiologically compatible salts or derivatives of NADH and/or NADPH are administered to a person suffering from the syndrome or its symptoms. Patients so treated exhibit greatly improved physical strength and performance over time, and their symptoms including fatigue, muscle pain and weakness, and headaches are greatly alleviated.
申请公布号 US5712259(A) 申请公布日期 1998.01.27
申请号 US19960636202 申请日期 1996.04.22
申请人 BIRKMAYER PHARMACEUTICALS 发明人 BIRKMAYER, JOERG G. D.
分类号 A61K31/70;(IPC1-7):A61K31/70 主分类号 A61K31/70
代理机构 代理人
主权项
地址